We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

COVID-19 Portal Will Provide Scientists Free Access to Completed Clinical Trial Data

Article   Mar 24, 2020 | By Laura Elizabeth Lansdowne, Senior Science Writer, Technology Networks

 
COVID-19 Portal Will Provide Scientists Free Access to Completed Clinical Trial Data

Laura Elizabeth Lansdowne

Senior Science Writer

 
 
Advertisement
 

RELATED ARTICLES

Talking Viral Mutations, Genome Sequencing and Antigenic Drift With Dr Timothy Triche

Article

Technology Networks interviewed Dr Timothy Triche to gain his perspectives on how analysis of unique strains can help to define the scope and severity of COVID-19, why this is a complex process and the possible negative implications of antigenic drift.

READ MORE

Antimicrobial Resistance

Article

Antimicrobial resistance (AMR) is the ability of microorganisms to resist the killing capacity of antimicrobial drugs, a worryingly increasing problem. This article explores the science behind AMR, factors promoting it's spread and techniques to detect it. Looking to the future, ways to combat AMR and alternatives to antimicrobials are discussed.

READ MORE

Identifying and Optimizing a Promising Drug

Article

In a recent interview with Technology Networks, Prof. Paul Brennan from the University of Oxford explains that proteins “make up approximately 60% of what is in a cell.” So, it is no surprise that almost all approved drugs act by targeting these complex macromolecules.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Informatics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE